Antitumor efficacy of lidamycin on hepatoma and active moiety of its molecule
about
Lidamycin shows highly potent cytotoxic to myeloma cells and inhibits tumor growth in miceSimultaneous determination of lidamycin enediyne chromophore (LDC) and its aromatized derivative (LDCA) using puerarin as internal standard in rat plasma by LC-MS/MS.Evaluation of the effects of nicorandil and its molecular precursor (without radical NO) on proliferation and apoptosis of 786-cellSalinomycin efficiency assessment in non-tumor (HB4a) and tumor (MCF-7) human breast cells.A Gelatinases-targeting scFv-based Fusion Protein Shows Enhanced Antitumour Activity with Endostar against Hepatoma.Chemiluminescent detection of cell apoptosis enzyme by gold nanoparticle-based resonance energy transfer assay.Lidamycin up-regulates the expression of thymidine phosphorylase and enhances the effects of capecitabine on the growth and pulmonary metastases of murine breast carcinoma.Antitumor effects of an engineered and energized fusion protein consisting of an anti-CD20 scFv fragment and lidamycin.Inhibition of mouse embryonic carcinoma cell growth by lidamycin through down-regulation of embryonic stem cell-like genes Oct4, Sox2 and Myc.Efficient inhibition of B-cell lymphoma xenografts with a novel recombinant fusion protein: anti-CD20Fab-LDM.Synergy of gemcitabine and lidamycin associated with NF-kappaB downregulation in pancreatic carcinoma cells.Evaluation of lignan (-)-cubebin extracted from Piper cubeba on human colon adenocarcinoma cells (HT29).Generation and antitumor effects of an engineered and energized fusion protein VL-LDP-AE composed of single-domain antibody and lidamycin.
P2860
Q33477869-EE9AD93A-C087-41AE-BAFF-E49A5573C31DQ33989040-EA161648-A648-4AC4-96F5-8D6FF3D1ED82Q37668244-57B3F58B-DB67-470F-A6EE-6A8443C53011Q38789781-E07B5CAE-DD23-4860-9FDF-9231E1492A74Q38917149-D42B72B7-ACE5-4203-9C10-083FBF92D6B8Q39028715-67F8648B-5D71-45FA-974C-3F2697ADC206Q39105402-B42702E8-5DC8-4CCD-82A7-333EB045D711Q39574303-C171E97E-7AED-4081-8CD6-35CD6C4BDBCDQ39685735-DD6FA380-B4E4-4F22-AC49-CDF2AEBB4A71Q39704501-558DF8CE-45B8-4DA5-91AA-75C49860E92AQ39989439-85104FC7-89BF-4430-B8E6-09D207DE0C05Q40053109-226598D2-7947-45F6-991B-47983EA0F8DAQ40102449-7C12A8E2-F02B-4BAF-98F3-1CA75C82688F
P2860
Antitumor efficacy of lidamycin on hepatoma and active moiety of its molecule
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Antitumor efficacy of lidamycin on hepatoma and active moiety of its molecule
@ast
Antitumor efficacy of lidamycin on hepatoma and active moiety of its molecule
@en
type
label
Antitumor efficacy of lidamycin on hepatoma and active moiety of its molecule
@ast
Antitumor efficacy of lidamycin on hepatoma and active moiety of its molecule
@en
prefLabel
Antitumor efficacy of lidamycin on hepatoma and active moiety of its molecule
@ast
Antitumor efficacy of lidamycin on hepatoma and active moiety of its molecule
@en
P2093
P2860
P356
P1476
Antitumor efficacy of lidamycin on hepatoma and active moiety of its molecule
@en
P2093
Bo-Yang Shang
Yong-Su Zhen
Yun-Hong Huang
P2860
P304
P356
10.3748/WJG.V11.I26.3980
P407
P577
2005-07-01T00:00:00Z